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Embryonic bcvine tracheal (EBTr) cells were found to possess receptors for endothelin (ET) of ET-l-selective (ET,,) subtype with a & for ET-l 
of II4 pM and a S,,, of 12.9 ~mol/105cells. Stimulationof EBTr cells with 100 pM to IOOnM ET-l increased thecontents ofbothinositolphosphates 
and CAMP in a concentration-dependent manner. indicating that the receplors are coupled to both phosphatidylinositol hydrolysis and CAMP 
formation in EBTr cells. 
Endothelin; Receptor: CAMP; Phosphatidylinositol turnover 
1. 1NTRODUCTION 
Endothclin, now known as ET-l, was first purified 
from the culture medium of porcine endothelial cells 
and is the most potent and long-acting vasoconstrictor 
[l]. Subsequently, ET-l has been shown to be a member 
of a family consisting of three isopeptides (ET-l, ET-2 
and ET-3) [2]. These ET isopeptides exhibit various 
pharmacological ctions including bronchoconstriction 
and vasodilation [3], which are mediated by two re- 
ceptor subtypes, i.e. ET-l- and ET-2-selective ETA and 
non-isopeptide-selective ETs [4-71. 
Both ET-receptors have been shown to mediate the 
stimulation of phosphatidylinositol (PI) hydrolysis in 
me.?y tissues and different cell types [3]. However, in- 
tracellular signal transduction involved in the ET re- 
ceptors seems to be more complex, because E’Cs 
reportedly inhibit CAMP formation in several tissues 
and cells [S-lo] and even stimulate the CAMP genera- 
tion in a few systems uch as cultured rat epididymal 
cells [1 1] and glomerular mesangial cells [12]. 
r:bbrc~~iurions: EBTr cell:.. embryonic bovine tracheal cells; ET, endo- 
thclin; PI, phosphatidyli:.ositol; IBMX, 3-isobutyl-I-methylxanthine: 
TPA, I?-CI-tetrudccaco; lphorbol 13.acetate; PG. prostaglandin: 
DMEM. Dulbecco’s mcdified Eagle’s medium: NEPES. N-2.hvd- 
roxyethylpipcrazinc.~~~~l-ethanesul~onicacid;HBSS,HEP~S-buffe;ed 
salt solution; [Ca2’],. i:ltraccllular Ca?’ concentration; IP, inositol 
phosphate; IP,, inositc’l rrlnnophosphart, lP,. inositol bisphosphatc: 
IP,, inositol trisphosphate. 
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In this paper, we show first that ETA receptors are 
abundant in EBTr cells, a cell line derived from the 
embryonic bovine trachea. We also reveal that the ETA 
receptor is coupled to both PI hydrolysis and CAMP 
formation in EBTr cells. The present study is the first 
to show that ETA receptors arc coupled to both PI 
hydrolysis and CAMP formation. 
2. MATERIALS AND METHODS 
ET-I and ET-3 were obtained from Peptide Institute Inc. (Osaka, 
Japan). 3-lsobutyl-I-methylxanthine (IBMX) and 12-O-tetradeca- 
noylphorbol 13.acetate (TPA) were obtained from Sigma and fura-Z 
acetoxymcthyl ester was from Dojin (Kumamoto, Japan). Prosta- 
giandin (PG) Dz and AH6809 were generous gilks from Ono Phar- 
maceuticals (Osaka, Japan) and Glaxo (Hertfo:dshirc, UK), respcc 
tively. [1z51]ET-I (74 TBqlmmol), [‘z’l]ET-3 (74. TBqlmmol) and 
pH]inositol (699 GBq/mmol) were purchnscd from Amcrsham. All 
other chemicals were of reagent grade. 
EBTr cells (27th passage) were obtained from the American Type 
Cell Culture Collection (ATCC CCL 44) andcultured with Dulbesco’s 
modilied Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum at 37°C in a CO> incubator (5% COd95% air) as previ- 
ously reported [ 131, EBTr cells of the 30th to 35th passage were used 
for experiments. 
2.3. Bkding USSUJf 
EBTr cells were cultured to confluence on 24-well plates (2x10’ 
cells/well). The cells were washed with 20 mM HEPES (pH 7.4). 
containing 140 mM N&l. 4 mM KCI. I mM KlHPQ, 1 mM MgC12. 
I mM CaCIL 10 mM ~q$scm and 0.05% bovine serum albumin 
(HBSS) and incubated at 37°C for I h in HBSS with various con- 
centrdlions of [I-ilET- to obtain total binding. Nonspeciiic binding 
was determined in the presence of 100 nM unlatxled ET-l. Specific 
binding was defined as total binding minus nonspecific binding. The 
187 






0 5 IO 
Bound (fmolil O5 cells) 
15 0 12 11 10 9 8 7 6 
Unlabeled ET (-log M) 
Fig. I. Ecatchard analysis of the specific binding of [‘zSI]ET-I to EBTr cells (A). Competitive binding of 50 pM [1r51]ET-I to EBTt cells by unlabeled 
ET-I (0) and ET-3 (0) (B). Results are expressed as percentages of the specific bindin?. Values are the means of triplicate determinations. 
cell-associated radioactivity wasdissolved in I N NaOH and measured 
in a Wallac-1470 Wizard autogamma counter (Pharmacia). 
2.4. Mcustmtttutf of intracrhlur CC-?” cottcm-afion ((Ca?+l,) 
EBTr cells cultured on quartz slide-glass were washed three times 
in a serum-free DMEM and incubated with 5 PM fura-2-acetoxy- 
methyl ester at 37°C for I .5 h in a CO? incubator. After washing three 
times in HBSS, the fura-a-loaded EBTr cells were transferred to a 
chamber on the stage of a Mu-IO Cal’ analyzer (Inter Dee, Osaka, 
Japan). The change of [Caz+], was monitored fluorimetrically with the 
emission wavelength set at 510 nm and the excitation wavelengths at
340 and 380 nm. The [Ca!*], was estimated from the ratio of Ruores- 
cence at 340 nm to that at 380 nm by using a standard curve obtained 
with various concentrations of free Ca?‘. 
2.5. hfexwrnnmr oj inositol phovpltate (iP) _Gormnliotl 
EBTr cells were cultured in 6-well plates at a density of 9x10’ cells’ 
well. The cells were labeled with [‘H]inositol (74 kBq/well) for 1 day 
in inositol-free DMEM supplemented witli 10% dialyzed fetal bovine 
serum. The formation oflP,, KPs and IP, was determined as dcscribud 
previously [l4]. 
2.6. Mtwstrwncnt of CAMP formation 
The CAMP content of cells was determined in the presence of 0.5 
mM IBMX, an inhibitor ofphosphodiesterase, as reported previously 
[13]. EBTr cells grown to confluence in 24.well plates were washed 
twice with 1 ml of HBSS before experiments. After preincubation at 
37OC for IO rnin with 1 ml of HBSS containing 0.5 mM IBMX, the 
cells were incubated with various amounts of ET-I or ET-3 at 37’C 
for 10 min exxpt when otherwise indicated. The reaction was stopped 
by addition of 10% (w/v) trichloroacetic acid. The CAMP content was 
measured by radioimmunoassay with an [lJ51]cAMP assay kit 
(Amersham). 
3. RESULTS AND DISCUSSION 
‘We detected the specific binding of [lzSI]ET- I to EBTr 
cells. The Scatchard analysis (Fig. 1A) revealed a single 
component of high affinity binding sites for ET-l with 
a dissociation constant (Kd) of 114 pM and a maximum 
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binding capacity (B,,,) of 12.9 fmol/lO’ cells. In con- 
trast, when [‘z51]ET-3 was used as a ligand, no specific 
binding was detected on EBTr cells. In competitive 
binding assays (Fig. lB), unlabeled ET-l dose-depcn- 
dently and completely inhibited the binding of [“51]ET- 
1 to EBTr cells, showing a K, of 140 pM. Although 
unlabeled ET-3 also competed with [?]ET-1 on the 
same binding sites, the Ki value of ET-3 (160 nM) was 
l,lOO-fold higher than that of unlabeled ET-I, indi- 
cating that the ET-1 !;elective subtype of ET receptor 
(ET,) is responsible filr the binding of ET-l to EBTr 
cells. 
The Kd value of the ETA receptor on EBTr cells is 
-2-fold higher than that of the ET, receptor (53 p?.!l) 
on A-10 cells derived from rat aortic smooth muscle, 
which are used for a model of ET-induced vascular 
contraction, and -7-fold that of endothelial ETs re- 
ceptor (17 pM), which is coupled to ET-induced va- 
sodilation [IS]. This may explain, in part, pharma- 
cological observations that bronchoconstriction re- 
quires higher amounts of ETs [16] as compared with 
vasoconstriction or vasodilation [17]. On the other 
hand, the number of ETA receptors of EBTr cells 
(78,000 sites/cell) is -4-fold more than that of the ET,., 
receptor on A-10 cells (21,000 sites/cell) and -16-fold 
that of th;: ETa receptor on cndathelial cells (>5,000 
sites/cell). 
ET-l induced a rapid and transient increase in [Ca2’], 
accompanied with PI hydrolysis and CAMP formation 
in EDTr cells. Fig. 2A shows typical time courses of 
incr.eases in those intracellular second messengers in- 
duced by 10 nM ET-l. After addition of 10 n-M ET-l, 
[Ca”‘], incr eased immediately from the basal level (120 
nM) to a ;3eak (450 nM) at about 20 s, decreased rapidly 
to a sustLned level (230 nM) by 1 min, and maintained 
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Fig. 2. (A) Time course of ICa?-I,, PI hydrolysis, and CAMP content in EBTr cells after incubation with 10 nM ET-1 (0) and ET.3 !O). (Bl 
Dose-response curvti ol’el‘-I (0) and IX-3 (@I for increases in[Ca?+],, Pi hydrolysis and CAMP fOrrlutirSn i  X3Tr &is. The [Ca’*l was eslimalcd 
at the peak value after addition of ETs, The formation of 1Ps and CAMP was dctcrmincd after incubation for 10 min. The vnluti of 1Ps md CAMP 
arc means 2 S.D. of four determinations. 
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Fig. 3. Effects of various compounds on the increase in the CAMP 
content in EBTr cells. The CAMP content was determined after in- 
cubation for 10 min with 10 nM ET-I. 100 nM PGD,. 1 uM iono- 
mycin, I yM A-23187, 10 @I arachidonic acid, or I%0 nM TPA. 
AH6809 (100pM) or indomethacin (Indo.) (50pM) was added 10 min 
bcforc various stimulation. The values are means + SD. of four 
determinations. 
the sustained level for a further 10 min. A rapid rise in 
t’H]IP, formation was observed at 30 s, reaching a max- 
m~um level of 243% of the control at 2 min. [“H]IP, 
formation could be also detected at 30 s and increased 
continuously over a LO-min period. In contrast, [“H]IP, 
accumulation was detectable only after 2 min and then 
increased Wn- ,,,,,.ly. The CAMP content increased almost 
linearly after addition of ET-1 and reached to a plateau 
level of -Cfold of the basal evel by 5 min. As shown 
in Fig. 2B, te increases in [Ca”li, IPs and CAMP were 
dose-dependent over the concentrations from 100 pM 
to 100 nM of ET- I. The half-maximal stimulation of IPj 
and CAMP contents occurred at -500 pM, which is in 
the same order of the Kd value (114 PM) of ETA re- 
ceptors on EBTr cells. However, ET-3 did not affect 
[Ca”]i, PI hydrolysis, nor CAMP content in EBTr cells 
at concentrations up to 10 nM. At the maximum con- 
cemration (100 nM) of ET-3 used in this study, [Ca’+]i 
and IPs increased only slightly while the CAMP content 
remained unchanged. 
EBTr cells also have receptors fcr PGD, coupled to 
adenylate cyclase [131. However, the ET-l-induced in- 
crease in the CAMP content was not at all affected by 
the presence of 50 ,uM indomethacn, a cyclooxygenase 
inhibitor, nor of 100,clM AH6809, an antagonist for the 
PGDz-receptor (Fig. 3). The indomethacin-treatment 
inhibits the biosynthesis of PGs in various types of cells 
and AH6809 blocked completely the PGD2-receptor- 
mediated increase in the CAMP content in EBTr cells 
[18]. Furthermore, the CAMP content in EBTr cells was 
unchanged by incubation with Ca’+ ionophores (1 ,ULLM 
ionomycin, I PM A-23 187), arachidonic acid (10 PM) 
or phorbol ester (100 nM TPA) (Fig. 3). These results 
indicate that the CAMP formation in EBTr cells induced 
by ET-l was not a secondary effect mediated by the 
increase in [Ca”‘]i and activation of protein kinase C 
resulting from PI hydrolysis. 
The present study is the first to show that ETA re- 
ceptors are coupled to both PI hydrolysis and CAMP 
formation. In rat epididymal epithelial cells, ET-1 
reportedly causes a rise in CAMP with no effect on 
[Ca’*]i or IP contents [I l]. In rat glomerular mesangial 
cells, ET-I potentiates l3-adrenergic-stimulated CAMP 
accumulation by a PGE,-dependent mechanism, which 
is completely blocked by a IO-min preincubation with 
10 yM indomethacin [12]. Similar dual coupling to PI 
hydrolysis and CAMP formation has been demonstrated 
to be involved in the signal transduction of thyrotropin 
receptors [19], tachykinin receptors [20], and recom- 
binant chimeric receptors of i3-adrenergic and m 1 mus- 
carinic acetylcholine receptors [2l]. On the other hand, 
secondary CAMP formation, which is mediated by PI 
hydrolysis, has been found in t!le case of ml muscarinic 
acetylcholine receptors in human kidney cells and A9L 
cells [22,23], 
It is likely that the ET,., receptor in EBTr cells is 
linked through two differert s;jTP-binding proteins, Gp 
(Gq) and Gs, to two effector systems, phospholipuse C
and adenylate cyclase. Further evidence for the coup- 
ling of the ETA receptor to GTP-binding proteins will 
be provided in studies with membranes of EBTr cells. 
Studies along these lines are now in progress. 
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